Evaluation of epidermal growth factor receptor, transforming growth factor alpha, epidermal growth factor and c-erbB2 in the progression in invasive bladder cancer

V. Ravery, David Grignon, J. Angulo, E. Pontes, J. Montie, J. Crissman, D. Chopin

Research output: Contribution to journalArticle

75 Citations (Scopus)

Abstract

Introduction: Determination of the risk of invasive bladder tumors progressing is still imprecise due to the heterogeneous biological behavior of this neoplasm. The goals of this study were to evaluate the patterns of expression of the epidermal growth factor (EGF) system in invasive bladder cancer and to assess its prognostic value. Methods: This immunohistochemical study was performed using fresh frozen tumor samples and a panel of monoclonal antibodies on a series of 43 invasive bladder cancers treated by cystectomy. Results: EGF was detected in 45% of the tumors and did not correlate with survival from bladder cancer. Transforming growth factor alpha (TGFα) was expressed by 60% of the tumors and correlated strongly with death from bladder cancer. Epidermal growth factor receptor (EGF-R) expression was seen in 86% of cases and had no prognostic significance. c-erbB2 was expressed in 50% of cases and was inversely related to a poor prognosis. When EGF and TGFα were both expressed, there was little or no expression of c-erbB2. Conclusion: The accumulation of several growth factors and the relevant receptor are necessary for the progression of invasive bladder cancers. They could be used as indicators of tumor aggressiveness.

Original languageEnglish (US)
Pages (from-to)9-17
Number of pages9
JournalUrological Research
Volume25
Issue number1
DOIs
StatePublished - Feb 1997
Externally publishedYes

Fingerprint

Transforming Growth Factor alpha
Epidermal Growth Factor Receptor
Epidermal Growth Factor
Urinary Bladder Neoplasms
Neoplasms
Growth Factor Receptors
Cystectomy
Monoclonal Antibodies

Keywords

  • bladder cancer
  • EGF
  • growth factors
  • invasive tumors
  • prognosis
  • receptor

ASJC Scopus subject areas

  • Urology

Cite this

Evaluation of epidermal growth factor receptor, transforming growth factor alpha, epidermal growth factor and c-erbB2 in the progression in invasive bladder cancer. / Ravery, V.; Grignon, David; Angulo, J.; Pontes, E.; Montie, J.; Crissman, J.; Chopin, D.

In: Urological Research, Vol. 25, No. 1, 02.1997, p. 9-17.

Research output: Contribution to journalArticle

@article{0993220dda0f4557b260dddc2f77db2e,
title = "Evaluation of epidermal growth factor receptor, transforming growth factor alpha, epidermal growth factor and c-erbB2 in the progression in invasive bladder cancer",
abstract = "Introduction: Determination of the risk of invasive bladder tumors progressing is still imprecise due to the heterogeneous biological behavior of this neoplasm. The goals of this study were to evaluate the patterns of expression of the epidermal growth factor (EGF) system in invasive bladder cancer and to assess its prognostic value. Methods: This immunohistochemical study was performed using fresh frozen tumor samples and a panel of monoclonal antibodies on a series of 43 invasive bladder cancers treated by cystectomy. Results: EGF was detected in 45{\%} of the tumors and did not correlate with survival from bladder cancer. Transforming growth factor alpha (TGFα) was expressed by 60{\%} of the tumors and correlated strongly with death from bladder cancer. Epidermal growth factor receptor (EGF-R) expression was seen in 86{\%} of cases and had no prognostic significance. c-erbB2 was expressed in 50{\%} of cases and was inversely related to a poor prognosis. When EGF and TGFα were both expressed, there was little or no expression of c-erbB2. Conclusion: The accumulation of several growth factors and the relevant receptor are necessary for the progression of invasive bladder cancers. They could be used as indicators of tumor aggressiveness.",
keywords = "bladder cancer, EGF, growth factors, invasive tumors, prognosis, receptor",
author = "V. Ravery and David Grignon and J. Angulo and E. Pontes and J. Montie and J. Crissman and D. Chopin",
year = "1997",
month = "2",
doi = "10.1007/BF00941900",
language = "English (US)",
volume = "25",
pages = "9--17",
journal = "Urolithiasis",
issn = "2194-7228",
publisher = "Springer Verlag",
number = "1",

}

TY - JOUR

T1 - Evaluation of epidermal growth factor receptor, transforming growth factor alpha, epidermal growth factor and c-erbB2 in the progression in invasive bladder cancer

AU - Ravery, V.

AU - Grignon, David

AU - Angulo, J.

AU - Pontes, E.

AU - Montie, J.

AU - Crissman, J.

AU - Chopin, D.

PY - 1997/2

Y1 - 1997/2

N2 - Introduction: Determination of the risk of invasive bladder tumors progressing is still imprecise due to the heterogeneous biological behavior of this neoplasm. The goals of this study were to evaluate the patterns of expression of the epidermal growth factor (EGF) system in invasive bladder cancer and to assess its prognostic value. Methods: This immunohistochemical study was performed using fresh frozen tumor samples and a panel of monoclonal antibodies on a series of 43 invasive bladder cancers treated by cystectomy. Results: EGF was detected in 45% of the tumors and did not correlate with survival from bladder cancer. Transforming growth factor alpha (TGFα) was expressed by 60% of the tumors and correlated strongly with death from bladder cancer. Epidermal growth factor receptor (EGF-R) expression was seen in 86% of cases and had no prognostic significance. c-erbB2 was expressed in 50% of cases and was inversely related to a poor prognosis. When EGF and TGFα were both expressed, there was little or no expression of c-erbB2. Conclusion: The accumulation of several growth factors and the relevant receptor are necessary for the progression of invasive bladder cancers. They could be used as indicators of tumor aggressiveness.

AB - Introduction: Determination of the risk of invasive bladder tumors progressing is still imprecise due to the heterogeneous biological behavior of this neoplasm. The goals of this study were to evaluate the patterns of expression of the epidermal growth factor (EGF) system in invasive bladder cancer and to assess its prognostic value. Methods: This immunohistochemical study was performed using fresh frozen tumor samples and a panel of monoclonal antibodies on a series of 43 invasive bladder cancers treated by cystectomy. Results: EGF was detected in 45% of the tumors and did not correlate with survival from bladder cancer. Transforming growth factor alpha (TGFα) was expressed by 60% of the tumors and correlated strongly with death from bladder cancer. Epidermal growth factor receptor (EGF-R) expression was seen in 86% of cases and had no prognostic significance. c-erbB2 was expressed in 50% of cases and was inversely related to a poor prognosis. When EGF and TGFα were both expressed, there was little or no expression of c-erbB2. Conclusion: The accumulation of several growth factors and the relevant receptor are necessary for the progression of invasive bladder cancers. They could be used as indicators of tumor aggressiveness.

KW - bladder cancer

KW - EGF

KW - growth factors

KW - invasive tumors

KW - prognosis

KW - receptor

UR - http://www.scopus.com/inward/record.url?scp=0030951820&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030951820&partnerID=8YFLogxK

U2 - 10.1007/BF00941900

DO - 10.1007/BF00941900

M3 - Article

C2 - 9079740

AN - SCOPUS:0030951820

VL - 25

SP - 9

EP - 17

JO - Urolithiasis

JF - Urolithiasis

SN - 2194-7228

IS - 1

ER -